ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0218

Synovitis Does Not Mediate the Relationship Between Body Mass Index and Progression of Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative

Marina Bañuls1, Alecio Lombardi1, Eric Chang1, Aladdin H Shadyab1, Nancy Lane2 and Monica Guma3, 1University of California San Diego, San Diego, CA, 2University of California Davis, Hillsborough, CA, 3University of California San Diego, La Jolla, CA

Meeting: ACR Convergence 2021

Keywords: Osteoarthritis, radiography, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Osteoarthritis – Clinical Poster I (0210–0224)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Synovial inflammation is associated with knee osteoarthritis (KOA) progression. Body mass index (BMI) has also been associated with KOA progression. Yet, it is unclear whether synovial inflammation mediates the association of BMI with KOA progression. Here, we examined the mediating effect of synovitis in the association between BMI and progression of radiographic KOA in the Osteoarthritis Initiative (OAI) cohort.

Methods: We conducted a case-control study within the OAI. Cases (n = 315) were right knees with an increase of ≥ 1 Kellgren-Lawrence (K-L) from baseline to 48 months of follow-up. Controls (n = 315) were right knees that had no K-L change over 48 months. Cases and controls were matched by age, gender, race and baseline K-L. MRI Osteoarthritis Knee Score (MOAKS) was used for a semi-quantitative evaluation (0-3) of effusion synovitis and Hoffa-synovitis at baseline. The SPSS PROCESS macro was used to test the mediating effects.

Results: The mean age of participants was 61 years, 70.8% were women, and 87% were white. Baseline knee KL was as follows: 36.8% grade 0, 30.2% grade 1, 25.1% grade 2 and 7.9% grade 3. 24.9% were normal weight (BMI < 24.9 kg/m2), 37.1% were overweight (BMI 25-29.9 kg/m2) and 37.0% were obese (BMI ≥ 30 kg/m2). Average BMI was 28.63 ± 4.8. 49.8% had synovitis effusion with a score of 0.56 ± 0.6, and 51.9% had Hoffa synovitis with a score or 0.61 ± 0.66. Compared with controls, cases had higher BMI (29.1 ± 4.7 vs 28.2 ± 4.9,p< 0.05), and were more likely to be obese (41.5% vs. 34.3%) than controls (p < 0.05). At baseline, cases had higher prevalence of both synovitis effusion and Hoffa-synovitis than controls (59.6% vs 40.1%, p< 0.01 for synovitis-effusion and 61.9% vs 42%, p< 0.01, for Hoffa synovitis respectively). Yet, in the mediation analysis, neither synovitis effusion nor Hoffa synovitis mediated the relationship between BMI and KOA progression.

Conclusion: Preliminary findings from mediation analysis showed that neither synovitis effusion nor Hoffa synovitis mediated the relationship between BMI and progression of radiographic KOA over a 4-year period. A longer duration of follow-up may be required to determine if synovitis mediates the association between BMI and progression of KOA.

Figure 1: Patient selection from the OAI database

Table 1: Baseline characteristics of the study participants

Figure 2. A: Percentage of cases and controls by BMI. P value is overall test of significant for chi square test.
Figure 2. B: Percentage of cases and controls with synovitis effusion or Hoffa synovitis. P value is overall test of significant for chi square test.


Disclosures: M. Bañuls, None; A. Lombardi, None; E. Chang, None; A. H Shadyab, None; N. Lane, Amgen, 2, Pfizer, 2, BriOri Biotech, 4, Makikroft, 2, 6, GSK, 2, UCB, 1; M. Guma, Novartis, 5, Pfizer, 5, Gilead, 5, Genentech, 5.

To cite this abstract in AMA style:

Bañuls M, Lombardi A, Chang E, H Shadyab A, Lane N, Guma M. Synovitis Does Not Mediate the Relationship Between Body Mass Index and Progression of Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/synovitis-does-not-mediate-the-relationship-between-body-mass-index-and-progression-of-radiographic-knee-osteoarthritis-data-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovitis-does-not-mediate-the-relationship-between-body-mass-index-and-progression-of-radiographic-knee-osteoarthritis-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology